RVPH
Reviva Pharmaceuticals Holdings, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$0.28
$-0.01
(-3.97%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $32.50M | EPS (ttm) | $-0.44 | Current Price | $0.28 |
| Enterprise Value | $18.81M | Forward EPS | $-0.27 | Previous Close | $0.29 |
| P/E Ratio | - | ROA | -130.48% | 52W High | $2.15 |
| Forward P/E | -1.04 | ROE | - | 52W Low | $0.25 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $0.44 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $0.55 |
| P/B Ratio | 5.92 | Profit Margin | - | Volume | 1.96M |
| EV/EBITDA | - | Current Ratio | 1.39 | Avg Volume | 5.32M |
| EV/Sales | - | Quick Ratio | 1.35 | Beta | 0.04 |
| Employees | 14.00 | Debt/Equity | - | Shares Outstanding | 116.85M |
| Sector | Healthcare | Total Debt | - | Float Shares | 111.60M |
| Industry | Biotechnology | Total Cash | $13.18M | Short Float | 21.06% |
| Optionable | Yes | Cash/Share | $0.12 | Short Ratio | 2.97 |
| Dividend Yield | - | Book Value/Share | $0.05 | % Held by Insiders | 4.23% |
| Target Price | $4.81 | Revenue (TTM) | - | % Held by Institutions | 10.95% |